- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Pierre Fabre Medicament
Total 149 results
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedRecurrent Upper-Respiratory Tract InfectionsItaly, Poland, Romania, Russian Federation, Lithuania
-
Pierre Fabre MedicamentTerminatedIron Deficiency AnemiaBulgaria, Romania
-
Pierre Fabre MedicamentCompletedBladder Transitional Cell Carcinoma Stage IVFrance
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedIschemic StrokeSpain, France, Switzerland, Germany, Sweden, Italy, Czech Republic, Portugal, Belgium, Hungary, Russian Federation
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedAcute Sore Throat PainUnited Kingdom, Germany, Latvia, France
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentNot yet recruiting
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
Pierre Fabre MedicamentActive, not recruiting
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
Pierre Fabre MedicamentCompletedMalignant Neoplasm of BreastChina, Taiwan, Singapore
-
Pierre Fabre MedicamentCompletedRecurrent or Metastatic Head and Neck CarcinomaFrance
-
Pierre Fabre MedicamentCompletedAtopic DermatitisFrance, Romania, Estonia, Poland, Lithuania
-
Pierre Fabre MedicamentCompletedBenign Prostatic Hyperplasia (BPH)France, Spain, Portugal, Italy
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSpain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden
-
Pierre Fabre MedicamentCompletedAtopic DermatitisEstonia, France, Lithuania, Poland, Romania
-
Pierre Fabre MedicamentWithdrawnHepatic Impairment | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationSpain, Czechia, Italy
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
Pierre Fabre MedicamentTerminated
-
Pierre Fabre MedicamentCompletedSchizophreniaRomania, Russian Federation, Hungary, Latvia, France
-
Pierre Fabre MedicamentCompletedChronic Venous Insufficiency (CVI)France
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedBenign Prostatic Hyperplasia (BPH)France, Italy, Germany, Spain, Czech Republic
-
Pierre Fabre MedicamentCompletedAlveolar OsteitisFrance, Lithuania, Latvia, Estonia
-
Pierre Fabre MedicamentCompletedOpen Cracked Heel in Diabetic Patients With PolyneuropathyFrance, Belgium
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedDrug-induced XerostomiaGermany
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSpain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden, Denmark, Poland, United Kingdom
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSwitzerland
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentWithdrawnKnee Osteoarthritis
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
Pierre Fabre Medical DevicesCompleted
-
UNICANCERPierre Fabre MedicamentRecruitingMetastatic Colorectal Cancer | BRAF V600E Mutation PositiveFrance